Global OTC Transdermal Analgesic Patches Supply, Demand and Key Producers, 2023-2029
The global OTC Transdermal Analgesic Patches market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global OTC Transdermal Analgesic Patches production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for OTC Transdermal Analgesic Patches, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of OTC Transdermal Analgesic Patches that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global OTC Transdermal Analgesic Patches total production and demand, 2018-2029, (K Units)
Global OTC Transdermal Analgesic Patches total production value, 2018-2029, (USD Million)
Global OTC Transdermal Analgesic Patches production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global OTC Transdermal Analgesic Patches consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: OTC Transdermal Analgesic Patches domestic production, consumption, key domestic manufacturers and share
Global OTC Transdermal Analgesic Patches production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global OTC Transdermal Analgesic Patches production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global OTC Transdermal Analgesic Patches production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global OTC Transdermal Analgesic Patches market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu, Mylan, Johnson & Johnson, Teva, Lingrui, Sanofi, Qizheng, Endo and Huarun 999, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World OTC Transdermal Analgesic Patches market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global OTC Transdermal Analgesic Patches Market, By Region:
1. How big is the global OTC Transdermal Analgesic Patches market?
2. What is the demand of the global OTC Transdermal Analgesic Patches market?
3. What is the year over year growth of the global OTC Transdermal Analgesic Patches market?
4. What is the production and production value of the global OTC Transdermal Analgesic Patches market?
5. Who are the key producers in the global OTC Transdermal Analgesic Patches market?
6. What are the growth factors driving the market demand?
This report studies the global OTC Transdermal Analgesic Patches production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for OTC Transdermal Analgesic Patches, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of OTC Transdermal Analgesic Patches that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global OTC Transdermal Analgesic Patches total production and demand, 2018-2029, (K Units)
Global OTC Transdermal Analgesic Patches total production value, 2018-2029, (USD Million)
Global OTC Transdermal Analgesic Patches production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global OTC Transdermal Analgesic Patches consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: OTC Transdermal Analgesic Patches domestic production, consumption, key domestic manufacturers and share
Global OTC Transdermal Analgesic Patches production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global OTC Transdermal Analgesic Patches production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global OTC Transdermal Analgesic Patches production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global OTC Transdermal Analgesic Patches market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu, Mylan, Johnson & Johnson, Teva, Lingrui, Sanofi, Qizheng, Endo and Huarun 999, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World OTC Transdermal Analgesic Patches market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global OTC Transdermal Analgesic Patches Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Lidocaine Patches
- Diclofenac Patches
- Indomethacin Patches
- Counter-Irritant Patches
- Others
- Pharmacy
- Clinic
- Others
- Hisamitsu
- Mylan
- Johnson & Johnson
- Teva
- Lingrui
- Sanofi
- Qizheng
- Endo
- Huarun 999
- GSK
- Haw Par
- Nichiban
- Laboratoires Genevrier
- BLUE-EMU
- IBSA Group
- Pfizer
- Performance Health
- Actavis
- Teikoku Seiyaku
- Novartis
1. How big is the global OTC Transdermal Analgesic Patches market?
2. What is the demand of the global OTC Transdermal Analgesic Patches market?
3. What is the year over year growth of the global OTC Transdermal Analgesic Patches market?
4. What is the production and production value of the global OTC Transdermal Analgesic Patches market?
5. Who are the key producers in the global OTC Transdermal Analgesic Patches market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 OTC Transdermal Analgesic Patches Introduction
1.2 World OTC Transdermal Analgesic Patches Supply & Forecast
1.2.1 World OTC Transdermal Analgesic Patches Production Value (2018 & 2022 & 2029)
1.2.2 World OTC Transdermal Analgesic Patches Production (2018-2029)
1.2.3 World OTC Transdermal Analgesic Patches Pricing Trends (2018-2029)
1.3 World OTC Transdermal Analgesic Patches Production by Region (Based on Production Site)
1.3.1 World OTC Transdermal Analgesic Patches Production Value by Region (2018-2029)
1.3.2 World OTC Transdermal Analgesic Patches Production by Region (2018-2029)
1.3.3 World OTC Transdermal Analgesic Patches Average Price by Region (2018-2029)
1.3.4 North America OTC Transdermal Analgesic Patches Production (2018-2029)
1.3.5 Europe OTC Transdermal Analgesic Patches Production (2018-2029)
1.3.6 China OTC Transdermal Analgesic Patches Production (2018-2029)
1.3.7 Japan OTC Transdermal Analgesic Patches Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 OTC Transdermal Analgesic Patches Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 OTC Transdermal Analgesic Patches Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World OTC Transdermal Analgesic Patches Demand (2018-2029)
2.2 World OTC Transdermal Analgesic Patches Consumption by Region
2.2.1 World OTC Transdermal Analgesic Patches Consumption by Region (2018-2023)
2.2.2 World OTC Transdermal Analgesic Patches Consumption Forecast by Region (2024-2029)
2.3 United States OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.4 China OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.5 Europe OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.6 Japan OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.7 South Korea OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.8 ASEAN OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.9 India OTC Transdermal Analgesic Patches Consumption (2018-2029)
3 WORLD OTC TRANSDERMAL ANALGESIC PATCHES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World OTC Transdermal Analgesic Patches Production Value by Manufacturer (2018-2023)
3.2 World OTC Transdermal Analgesic Patches Production by Manufacturer (2018-2023)
3.3 World OTC Transdermal Analgesic Patches Average Price by Manufacturer (2018-2023)
3.4 OTC Transdermal Analgesic Patches Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global OTC Transdermal Analgesic Patches Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for OTC Transdermal Analgesic Patches in 2022
3.5.3 Global Concentration Ratios (CR8) for OTC Transdermal Analgesic Patches in 2022
3.6 OTC Transdermal Analgesic Patches Market: Overall Company Footprint Analysis
3.6.1 OTC Transdermal Analgesic Patches Market: Region Footprint
3.6.2 OTC Transdermal Analgesic Patches Market: Company Product Type Footprint
3.6.3 OTC Transdermal Analgesic Patches Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: OTC Transdermal Analgesic Patches Production Value Comparison
4.1.1 United States VS China: OTC Transdermal Analgesic Patches Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: OTC Transdermal Analgesic Patches Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: OTC Transdermal Analgesic Patches Production Comparison
4.2.1 United States VS China: OTC Transdermal Analgesic Patches Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: OTC Transdermal Analgesic Patches Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: OTC Transdermal Analgesic Patches Consumption Comparison
4.3.1 United States VS China: OTC Transdermal Analgesic Patches Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: OTC Transdermal Analgesic Patches Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based OTC Transdermal Analgesic Patches Manufacturers and Market Share, 2018-2023
4.4.1 United States Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers OTC Transdermal Analgesic Patches Production Value (2018-2023)
4.4.3 United States Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023)
4.5 China Based OTC Transdermal Analgesic Patches Manufacturers and Market Share
4.5.1 China Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers OTC Transdermal Analgesic Patches Production Value (2018-2023)
4.5.3 China Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023)
4.6 Rest of World Based OTC Transdermal Analgesic Patches Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World OTC Transdermal Analgesic Patches Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Lidocaine Patches
5.2.2 Diclofenac Patches
5.2.3 Indomethacin Patches
5.2.4 Counter-Irritant Patches
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World OTC Transdermal Analgesic Patches Production by Type (2018-2029)
5.3.2 World OTC Transdermal Analgesic Patches Production Value by Type (2018-2029)
5.3.3 World OTC Transdermal Analgesic Patches Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World OTC Transdermal Analgesic Patches Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmacy
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World OTC Transdermal Analgesic Patches Production by Application (2018-2029)
6.3.2 World OTC Transdermal Analgesic Patches Production Value by Application (2018-2029)
6.3.3 World OTC Transdermal Analgesic Patches Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Hisamitsu
7.1.1 Hisamitsu Details
7.1.2 Hisamitsu Major Business
7.1.3 Hisamitsu OTC Transdermal Analgesic Patches Product and Services
7.1.4 Hisamitsu OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Hisamitsu Recent Developments/Updates
7.1.6 Hisamitsu Competitive Strengths & Weaknesses
7.2 Mylan
7.2.1 Mylan Details
7.2.2 Mylan Major Business
7.2.3 Mylan OTC Transdermal Analgesic Patches Product and Services
7.2.4 Mylan OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Mylan Recent Developments/Updates
7.2.6 Mylan Competitive Strengths & Weaknesses
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Details
7.3.2 Johnson & Johnson Major Business
7.3.3 Johnson & Johnson OTC Transdermal Analgesic Patches Product and Services
7.3.4 Johnson & Johnson OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Johnson & Johnson Recent Developments/Updates
7.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.4 Teva
7.4.1 Teva Details
7.4.2 Teva Major Business
7.4.3 Teva OTC Transdermal Analgesic Patches Product and Services
7.4.4 Teva OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Teva Recent Developments/Updates
7.4.6 Teva Competitive Strengths & Weaknesses
7.5 Lingrui
7.5.1 Lingrui Details
7.5.2 Lingrui Major Business
7.5.3 Lingrui OTC Transdermal Analgesic Patches Product and Services
7.5.4 Lingrui OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lingrui Recent Developments/Updates
7.5.6 Lingrui Competitive Strengths & Weaknesses
7.6 Sanofi
7.6.1 Sanofi Details
7.6.2 Sanofi Major Business
7.6.3 Sanofi OTC Transdermal Analgesic Patches Product and Services
7.6.4 Sanofi OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sanofi Recent Developments/Updates
7.6.6 Sanofi Competitive Strengths & Weaknesses
7.7 Qizheng
7.7.1 Qizheng Details
7.7.2 Qizheng Major Business
7.7.3 Qizheng OTC Transdermal Analgesic Patches Product and Services
7.7.4 Qizheng OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Qizheng Recent Developments/Updates
7.7.6 Qizheng Competitive Strengths & Weaknesses
7.8 Endo
7.8.1 Endo Details
7.8.2 Endo Major Business
7.8.3 Endo OTC Transdermal Analgesic Patches Product and Services
7.8.4 Endo OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Endo Recent Developments/Updates
7.8.6 Endo Competitive Strengths & Weaknesses
7.9 Huarun
7.9.1 Huarun 999 Details
7.9.2 Huarun 999 Major Business
7.9.3 Huarun 999 OTC Transdermal Analgesic Patches Product and Services
7.9.4 Huarun 999 OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Huarun 999 Recent Developments/Updates
7.9.6 Huarun 999 Competitive Strengths & Weaknesses
7.10 GSK
7.10.1 GSK Details
7.10.2 GSK Major Business
7.10.3 GSK OTC Transdermal Analgesic Patches Product and Services
7.10.4 GSK OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 GSK Recent Developments/Updates
7.10.6 GSK Competitive Strengths & Weaknesses
7.11 Haw Par
7.11.1 Haw Par Details
7.11.2 Haw Par Major Business
7.11.3 Haw Par OTC Transdermal Analgesic Patches Product and Services
7.11.4 Haw Par OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Haw Par Recent Developments/Updates
7.11.6 Haw Par Competitive Strengths & Weaknesses
7.12 Nichiban
7.12.1 Nichiban Details
7.12.2 Nichiban Major Business
7.12.3 Nichiban OTC Transdermal Analgesic Patches Product and Services
7.12.4 Nichiban OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Nichiban Recent Developments/Updates
7.12.6 Nichiban Competitive Strengths & Weaknesses
7.13 Laboratoires Genevrier
7.13.1 Laboratoires Genevrier Details
7.13.2 Laboratoires Genevrier Major Business
7.13.3 Laboratoires Genevrier OTC Transdermal Analgesic Patches Product and Services
7.13.4 Laboratoires Genevrier OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Laboratoires Genevrier Recent Developments/Updates
7.13.6 Laboratoires Genevrier Competitive Strengths & Weaknesses
7.14 BLUE-EMU
7.14.1 BLUE-EMU Details
7.14.2 BLUE-EMU Major Business
7.14.3 BLUE-EMU OTC Transdermal Analgesic Patches Product and Services
7.14.4 BLUE-EMU OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 BLUE-EMU Recent Developments/Updates
7.14.6 BLUE-EMU Competitive Strengths & Weaknesses
7.15 IBSA Group
7.15.1 IBSA Group Details
7.15.2 IBSA Group Major Business
7.15.3 IBSA Group OTC Transdermal Analgesic Patches Product and Services
7.15.4 IBSA Group OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 IBSA Group Recent Developments/Updates
7.15.6 IBSA Group Competitive Strengths & Weaknesses
7.16 Pfizer
7.16.1 Pfizer Details
7.16.2 Pfizer Major Business
7.16.3 Pfizer OTC Transdermal Analgesic Patches Product and Services
7.16.4 Pfizer OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Pfizer Recent Developments/Updates
7.16.6 Pfizer Competitive Strengths & Weaknesses
7.17 Performance Health
7.17.1 Performance Health Details
7.17.2 Performance Health Major Business
7.17.3 Performance Health OTC Transdermal Analgesic Patches Product and Services
7.17.4 Performance Health OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Performance Health Recent Developments/Updates
7.17.6 Performance Health Competitive Strengths & Weaknesses
7.18 Actavis
7.18.1 Actavis Details
7.18.2 Actavis Major Business
7.18.3 Actavis OTC Transdermal Analgesic Patches Product and Services
7.18.4 Actavis OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Actavis Recent Developments/Updates
7.18.6 Actavis Competitive Strengths & Weaknesses
7.19 Teikoku Seiyaku
7.19.1 Teikoku Seiyaku Details
7.19.2 Teikoku Seiyaku Major Business
7.19.3 Teikoku Seiyaku OTC Transdermal Analgesic Patches Product and Services
7.19.4 Teikoku Seiyaku OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Teikoku Seiyaku Recent Developments/Updates
7.19.6 Teikoku Seiyaku Competitive Strengths & Weaknesses
7.20 Novartis
7.20.1 Novartis Details
7.20.2 Novartis Major Business
7.20.3 Novartis OTC Transdermal Analgesic Patches Product and Services
7.20.4 Novartis OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Novartis Recent Developments/Updates
7.20.6 Novartis Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 OTC Transdermal Analgesic Patches Industry Chain
8.2 OTC Transdermal Analgesic Patches Upstream Analysis
8.2.1 OTC Transdermal Analgesic Patches Core Raw Materials
8.2.2 Main Manufacturers of OTC Transdermal Analgesic Patches Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 OTC Transdermal Analgesic Patches Production Mode
8.6 OTC Transdermal Analgesic Patches Procurement Model
8.7 OTC Transdermal Analgesic Patches Industry Sales Model and Sales Channels
8.7.1 OTC Transdermal Analgesic Patches Sales Model
8.7.2 OTC Transdermal Analgesic Patches Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 OTC Transdermal Analgesic Patches Introduction
1.2 World OTC Transdermal Analgesic Patches Supply & Forecast
1.2.1 World OTC Transdermal Analgesic Patches Production Value (2018 & 2022 & 2029)
1.2.2 World OTC Transdermal Analgesic Patches Production (2018-2029)
1.2.3 World OTC Transdermal Analgesic Patches Pricing Trends (2018-2029)
1.3 World OTC Transdermal Analgesic Patches Production by Region (Based on Production Site)
1.3.1 World OTC Transdermal Analgesic Patches Production Value by Region (2018-2029)
1.3.2 World OTC Transdermal Analgesic Patches Production by Region (2018-2029)
1.3.3 World OTC Transdermal Analgesic Patches Average Price by Region (2018-2029)
1.3.4 North America OTC Transdermal Analgesic Patches Production (2018-2029)
1.3.5 Europe OTC Transdermal Analgesic Patches Production (2018-2029)
1.3.6 China OTC Transdermal Analgesic Patches Production (2018-2029)
1.3.7 Japan OTC Transdermal Analgesic Patches Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 OTC Transdermal Analgesic Patches Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 OTC Transdermal Analgesic Patches Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World OTC Transdermal Analgesic Patches Demand (2018-2029)
2.2 World OTC Transdermal Analgesic Patches Consumption by Region
2.2.1 World OTC Transdermal Analgesic Patches Consumption by Region (2018-2023)
2.2.2 World OTC Transdermal Analgesic Patches Consumption Forecast by Region (2024-2029)
2.3 United States OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.4 China OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.5 Europe OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.6 Japan OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.7 South Korea OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.8 ASEAN OTC Transdermal Analgesic Patches Consumption (2018-2029)
2.9 India OTC Transdermal Analgesic Patches Consumption (2018-2029)
3 WORLD OTC TRANSDERMAL ANALGESIC PATCHES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World OTC Transdermal Analgesic Patches Production Value by Manufacturer (2018-2023)
3.2 World OTC Transdermal Analgesic Patches Production by Manufacturer (2018-2023)
3.3 World OTC Transdermal Analgesic Patches Average Price by Manufacturer (2018-2023)
3.4 OTC Transdermal Analgesic Patches Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global OTC Transdermal Analgesic Patches Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for OTC Transdermal Analgesic Patches in 2022
3.5.3 Global Concentration Ratios (CR8) for OTC Transdermal Analgesic Patches in 2022
3.6 OTC Transdermal Analgesic Patches Market: Overall Company Footprint Analysis
3.6.1 OTC Transdermal Analgesic Patches Market: Region Footprint
3.6.2 OTC Transdermal Analgesic Patches Market: Company Product Type Footprint
3.6.3 OTC Transdermal Analgesic Patches Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: OTC Transdermal Analgesic Patches Production Value Comparison
4.1.1 United States VS China: OTC Transdermal Analgesic Patches Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: OTC Transdermal Analgesic Patches Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: OTC Transdermal Analgesic Patches Production Comparison
4.2.1 United States VS China: OTC Transdermal Analgesic Patches Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: OTC Transdermal Analgesic Patches Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: OTC Transdermal Analgesic Patches Consumption Comparison
4.3.1 United States VS China: OTC Transdermal Analgesic Patches Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: OTC Transdermal Analgesic Patches Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based OTC Transdermal Analgesic Patches Manufacturers and Market Share, 2018-2023
4.4.1 United States Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers OTC Transdermal Analgesic Patches Production Value (2018-2023)
4.4.3 United States Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023)
4.5 China Based OTC Transdermal Analgesic Patches Manufacturers and Market Share
4.5.1 China Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers OTC Transdermal Analgesic Patches Production Value (2018-2023)
4.5.3 China Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023)
4.6 Rest of World Based OTC Transdermal Analgesic Patches Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World OTC Transdermal Analgesic Patches Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Lidocaine Patches
5.2.2 Diclofenac Patches
5.2.3 Indomethacin Patches
5.2.4 Counter-Irritant Patches
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World OTC Transdermal Analgesic Patches Production by Type (2018-2029)
5.3.2 World OTC Transdermal Analgesic Patches Production Value by Type (2018-2029)
5.3.3 World OTC Transdermal Analgesic Patches Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World OTC Transdermal Analgesic Patches Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmacy
6.2.2 Clinic
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World OTC Transdermal Analgesic Patches Production by Application (2018-2029)
6.3.2 World OTC Transdermal Analgesic Patches Production Value by Application (2018-2029)
6.3.3 World OTC Transdermal Analgesic Patches Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Hisamitsu
7.1.1 Hisamitsu Details
7.1.2 Hisamitsu Major Business
7.1.3 Hisamitsu OTC Transdermal Analgesic Patches Product and Services
7.1.4 Hisamitsu OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Hisamitsu Recent Developments/Updates
7.1.6 Hisamitsu Competitive Strengths & Weaknesses
7.2 Mylan
7.2.1 Mylan Details
7.2.2 Mylan Major Business
7.2.3 Mylan OTC Transdermal Analgesic Patches Product and Services
7.2.4 Mylan OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Mylan Recent Developments/Updates
7.2.6 Mylan Competitive Strengths & Weaknesses
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Details
7.3.2 Johnson & Johnson Major Business
7.3.3 Johnson & Johnson OTC Transdermal Analgesic Patches Product and Services
7.3.4 Johnson & Johnson OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Johnson & Johnson Recent Developments/Updates
7.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.4 Teva
7.4.1 Teva Details
7.4.2 Teva Major Business
7.4.3 Teva OTC Transdermal Analgesic Patches Product and Services
7.4.4 Teva OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Teva Recent Developments/Updates
7.4.6 Teva Competitive Strengths & Weaknesses
7.5 Lingrui
7.5.1 Lingrui Details
7.5.2 Lingrui Major Business
7.5.3 Lingrui OTC Transdermal Analgesic Patches Product and Services
7.5.4 Lingrui OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Lingrui Recent Developments/Updates
7.5.6 Lingrui Competitive Strengths & Weaknesses
7.6 Sanofi
7.6.1 Sanofi Details
7.6.2 Sanofi Major Business
7.6.3 Sanofi OTC Transdermal Analgesic Patches Product and Services
7.6.4 Sanofi OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Sanofi Recent Developments/Updates
7.6.6 Sanofi Competitive Strengths & Weaknesses
7.7 Qizheng
7.7.1 Qizheng Details
7.7.2 Qizheng Major Business
7.7.3 Qizheng OTC Transdermal Analgesic Patches Product and Services
7.7.4 Qizheng OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Qizheng Recent Developments/Updates
7.7.6 Qizheng Competitive Strengths & Weaknesses
7.8 Endo
7.8.1 Endo Details
7.8.2 Endo Major Business
7.8.3 Endo OTC Transdermal Analgesic Patches Product and Services
7.8.4 Endo OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Endo Recent Developments/Updates
7.8.6 Endo Competitive Strengths & Weaknesses
7.9 Huarun
7.9.1 Huarun 999 Details
7.9.2 Huarun 999 Major Business
7.9.3 Huarun 999 OTC Transdermal Analgesic Patches Product and Services
7.9.4 Huarun 999 OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Huarun 999 Recent Developments/Updates
7.9.6 Huarun 999 Competitive Strengths & Weaknesses
7.10 GSK
7.10.1 GSK Details
7.10.2 GSK Major Business
7.10.3 GSK OTC Transdermal Analgesic Patches Product and Services
7.10.4 GSK OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 GSK Recent Developments/Updates
7.10.6 GSK Competitive Strengths & Weaknesses
7.11 Haw Par
7.11.1 Haw Par Details
7.11.2 Haw Par Major Business
7.11.3 Haw Par OTC Transdermal Analgesic Patches Product and Services
7.11.4 Haw Par OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Haw Par Recent Developments/Updates
7.11.6 Haw Par Competitive Strengths & Weaknesses
7.12 Nichiban
7.12.1 Nichiban Details
7.12.2 Nichiban Major Business
7.12.3 Nichiban OTC Transdermal Analgesic Patches Product and Services
7.12.4 Nichiban OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Nichiban Recent Developments/Updates
7.12.6 Nichiban Competitive Strengths & Weaknesses
7.13 Laboratoires Genevrier
7.13.1 Laboratoires Genevrier Details
7.13.2 Laboratoires Genevrier Major Business
7.13.3 Laboratoires Genevrier OTC Transdermal Analgesic Patches Product and Services
7.13.4 Laboratoires Genevrier OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Laboratoires Genevrier Recent Developments/Updates
7.13.6 Laboratoires Genevrier Competitive Strengths & Weaknesses
7.14 BLUE-EMU
7.14.1 BLUE-EMU Details
7.14.2 BLUE-EMU Major Business
7.14.3 BLUE-EMU OTC Transdermal Analgesic Patches Product and Services
7.14.4 BLUE-EMU OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 BLUE-EMU Recent Developments/Updates
7.14.6 BLUE-EMU Competitive Strengths & Weaknesses
7.15 IBSA Group
7.15.1 IBSA Group Details
7.15.2 IBSA Group Major Business
7.15.3 IBSA Group OTC Transdermal Analgesic Patches Product and Services
7.15.4 IBSA Group OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 IBSA Group Recent Developments/Updates
7.15.6 IBSA Group Competitive Strengths & Weaknesses
7.16 Pfizer
7.16.1 Pfizer Details
7.16.2 Pfizer Major Business
7.16.3 Pfizer OTC Transdermal Analgesic Patches Product and Services
7.16.4 Pfizer OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Pfizer Recent Developments/Updates
7.16.6 Pfizer Competitive Strengths & Weaknesses
7.17 Performance Health
7.17.1 Performance Health Details
7.17.2 Performance Health Major Business
7.17.3 Performance Health OTC Transdermal Analgesic Patches Product and Services
7.17.4 Performance Health OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Performance Health Recent Developments/Updates
7.17.6 Performance Health Competitive Strengths & Weaknesses
7.18 Actavis
7.18.1 Actavis Details
7.18.2 Actavis Major Business
7.18.3 Actavis OTC Transdermal Analgesic Patches Product and Services
7.18.4 Actavis OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Actavis Recent Developments/Updates
7.18.6 Actavis Competitive Strengths & Weaknesses
7.19 Teikoku Seiyaku
7.19.1 Teikoku Seiyaku Details
7.19.2 Teikoku Seiyaku Major Business
7.19.3 Teikoku Seiyaku OTC Transdermal Analgesic Patches Product and Services
7.19.4 Teikoku Seiyaku OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Teikoku Seiyaku Recent Developments/Updates
7.19.6 Teikoku Seiyaku Competitive Strengths & Weaknesses
7.20 Novartis
7.20.1 Novartis Details
7.20.2 Novartis Major Business
7.20.3 Novartis OTC Transdermal Analgesic Patches Product and Services
7.20.4 Novartis OTC Transdermal Analgesic Patches Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Novartis Recent Developments/Updates
7.20.6 Novartis Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 OTC Transdermal Analgesic Patches Industry Chain
8.2 OTC Transdermal Analgesic Patches Upstream Analysis
8.2.1 OTC Transdermal Analgesic Patches Core Raw Materials
8.2.2 Main Manufacturers of OTC Transdermal Analgesic Patches Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 OTC Transdermal Analgesic Patches Production Mode
8.6 OTC Transdermal Analgesic Patches Procurement Model
8.7 OTC Transdermal Analgesic Patches Industry Sales Model and Sales Channels
8.7.1 OTC Transdermal Analgesic Patches Sales Model
8.7.2 OTC Transdermal Analgesic Patches Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World OTC Transdermal Analgesic Patches Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World OTC Transdermal Analgesic Patches Production Value by Region (2018-2023) & (USD Million)
Table 3. World OTC Transdermal Analgesic Patches Production Value by Region (2024-2029) & (USD Million)
Table 4. World OTC Transdermal Analgesic Patches Production Value Market Share by Region (2018-2023)
Table 5. World OTC Transdermal Analgesic Patches Production Value Market Share by Region (2024-2029)
Table 6. World OTC Transdermal Analgesic Patches Production by Region (2018-2023) & (K Units)
Table 7. World OTC Transdermal Analgesic Patches Production by Region (2024-2029) & (K Units)
Table 8. World OTC Transdermal Analgesic Patches Production Market Share by Region (2018-2023)
Table 9. World OTC Transdermal Analgesic Patches Production Market Share by Region (2024-2029)
Table 10. World OTC Transdermal Analgesic Patches Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World OTC Transdermal Analgesic Patches Average Price by Region (2024-2029) & (US$/Unit)
Table 12. OTC Transdermal Analgesic Patches Major Market Trends
Table 13. World OTC Transdermal Analgesic Patches Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World OTC Transdermal Analgesic Patches Consumption by Region (2018-2023) & (K Units)
Table 15. World OTC Transdermal Analgesic Patches Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World OTC Transdermal Analgesic Patches Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key OTC Transdermal Analgesic Patches Producers in 2022
Table 18. World OTC Transdermal Analgesic Patches Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key OTC Transdermal Analgesic Patches Producers in 2022
Table 20. World OTC Transdermal Analgesic Patches Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global OTC Transdermal Analgesic Patches Company Evaluation Quadrant
Table 22. World OTC Transdermal Analgesic Patches Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and OTC Transdermal Analgesic Patches Production Site of Key Manufacturer
Table 24. OTC Transdermal Analgesic Patches Market: Company Product Type Footprint
Table 25. OTC Transdermal Analgesic Patches Market: Company Product Application Footprint
Table 26. OTC Transdermal Analgesic Patches Competitive Factors
Table 27. OTC Transdermal Analgesic Patches New Entrant and Capacity Expansion Plans
Table 28. OTC Transdermal Analgesic Patches Mergers & Acquisitions Activity
Table 29. United States VS China OTC Transdermal Analgesic Patches Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China OTC Transdermal Analgesic Patches Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China OTC Transdermal Analgesic Patches Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers OTC Transdermal Analgesic Patches Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers OTC Transdermal Analgesic Patches Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share (2018-2023)
Table 37. China Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers OTC Transdermal Analgesic Patches Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers OTC Transdermal Analgesic Patches Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share (2018-2023)
Table 42. Rest of World Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share (2018-2023)
Table 47. World OTC Transdermal Analgesic Patches Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World OTC Transdermal Analgesic Patches Production by Type (2018-2023) & (K Units)
Table 49. World OTC Transdermal Analgesic Patches Production by Type (2024-2029) & (K Units)
Table 50. World OTC Transdermal Analgesic Patches Production Value by Type (2018-2023) & (USD Million)
Table 51. World OTC Transdermal Analgesic Patches Production Value by Type (2024-2029) & (USD Million)
Table 52. World OTC Transdermal Analgesic Patches Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World OTC Transdermal Analgesic Patches Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World OTC Transdermal Analgesic Patches Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World OTC Transdermal Analgesic Patches Production by Application (2018-2023) & (K Units)
Table 56. World OTC Transdermal Analgesic Patches Production by Application (2024-2029) & (K Units)
Table 57. World OTC Transdermal Analgesic Patches Production Value by Application (2018-2023) & (USD Million)
Table 58. World OTC Transdermal Analgesic Patches Production Value by Application (2024-2029) & (USD Million)
Table 59. World OTC Transdermal Analgesic Patches Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World OTC Transdermal Analgesic Patches Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Hisamitsu Basic Information, Manufacturing Base and Competitors
Table 62. Hisamitsu Major Business
Table 63. Hisamitsu OTC Transdermal Analgesic Patches Product and Services
Table 64. Hisamitsu OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Hisamitsu Recent Developments/Updates
Table 66. Hisamitsu Competitive Strengths & Weaknesses
Table 67. Mylan Basic Information, Manufacturing Base and Competitors
Table 68. Mylan Major Business
Table 69. Mylan OTC Transdermal Analgesic Patches Product and Services
Table 70. Mylan OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Mylan Recent Developments/Updates
Table 72. Mylan Competitive Strengths & Weaknesses
Table 73. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 74. Johnson & Johnson Major Business
Table 75. Johnson & Johnson OTC Transdermal Analgesic Patches Product and Services
Table 76. Johnson & Johnson OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Johnson & Johnson Recent Developments/Updates
Table 78. Johnson & Johnson Competitive Strengths & Weaknesses
Table 79. Teva Basic Information, Manufacturing Base and Competitors
Table 80. Teva Major Business
Table 81. Teva OTC Transdermal Analgesic Patches Product and Services
Table 82. Teva OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Teva Recent Developments/Updates
Table 84. Teva Competitive Strengths & Weaknesses
Table 85. Lingrui Basic Information, Manufacturing Base and Competitors
Table 86. Lingrui Major Business
Table 87. Lingrui OTC Transdermal Analgesic Patches Product and Services
Table 88. Lingrui OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lingrui Recent Developments/Updates
Table 90. Lingrui Competitive Strengths & Weaknesses
Table 91. Sanofi Basic Information, Manufacturing Base and Competitors
Table 92. Sanofi Major Business
Table 93. Sanofi OTC Transdermal Analgesic Patches Product and Services
Table 94. Sanofi OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sanofi Recent Developments/Updates
Table 96. Sanofi Competitive Strengths & Weaknesses
Table 97. Qizheng Basic Information, Manufacturing Base and Competitors
Table 98. Qizheng Major Business
Table 99. Qizheng OTC Transdermal Analgesic Patches Product and Services
Table 100. Qizheng OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Qizheng Recent Developments/Updates
Table 102. Qizheng Competitive Strengths & Weaknesses
Table 103. Endo Basic Information, Manufacturing Base and Competitors
Table 104. Endo Major Business
Table 105. Endo OTC Transdermal Analgesic Patches Product and Services
Table 106. Endo OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Endo Recent Developments/Updates
Table 108. Endo Competitive Strengths & Weaknesses
Table 109. Huarun 999 Basic Information, Manufacturing Base and Competitors
Table 110. Huarun 999 Major Business
Table 111. Huarun 999 OTC Transdermal Analgesic Patches Product and Services
Table 112. Huarun 999 OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Huarun 999 Recent Developments/Updates
Table 114. Huarun 999 Competitive Strengths & Weaknesses
Table 115. GSK Basic Information, Manufacturing Base and Competitors
Table 116. GSK Major Business
Table 117. GSK OTC Transdermal Analgesic Patches Product and Services
Table 118. GSK OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. GSK Recent Developments/Updates
Table 120. GSK Competitive Strengths & Weaknesses
Table 121. Haw Par Basic Information, Manufacturing Base and Competitors
Table 122. Haw Par Major Business
Table 123. Haw Par OTC Transdermal Analgesic Patches Product and Services
Table 124. Haw Par OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Haw Par Recent Developments/Updates
Table 126. Haw Par Competitive Strengths & Weaknesses
Table 127. Nichiban Basic Information, Manufacturing Base and Competitors
Table 128. Nichiban Major Business
Table 129. Nichiban OTC Transdermal Analgesic Patches Product and Services
Table 130. Nichiban OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Nichiban Recent Developments/Updates
Table 132. Nichiban Competitive Strengths & Weaknesses
Table 133. Laboratoires Genevrier Basic Information, Manufacturing Base and Competitors
Table 134. Laboratoires Genevrier Major Business
Table 135. Laboratoires Genevrier OTC Transdermal Analgesic Patches Product and Services
Table 136. Laboratoires Genevrier OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Laboratoires Genevrier Recent Developments/Updates
Table 138. Laboratoires Genevrier Competitive Strengths & Weaknesses
Table 139. BLUE-EMU Basic Information, Manufacturing Base and Competitors
Table 140. BLUE-EMU Major Business
Table 141. BLUE-EMU OTC Transdermal Analgesic Patches Product and Services
Table 142. BLUE-EMU OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. BLUE-EMU Recent Developments/Updates
Table 144. BLUE-EMU Competitive Strengths & Weaknesses
Table 145. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 146. IBSA Group Major Business
Table 147. IBSA Group OTC Transdermal Analgesic Patches Product and Services
Table 148. IBSA Group OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. IBSA Group Recent Developments/Updates
Table 150. IBSA Group Competitive Strengths & Weaknesses
Table 151. Pfizer Basic Information, Manufacturing Base and Competitors
Table 152. Pfizer Major Business
Table 153. Pfizer OTC Transdermal Analgesic Patches Product and Services
Table 154. Pfizer OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Pfizer Recent Developments/Updates
Table 156. Pfizer Competitive Strengths & Weaknesses
Table 157. Performance Health Basic Information, Manufacturing Base and Competitors
Table 158. Performance Health Major Business
Table 159. Performance Health OTC Transdermal Analgesic Patches Product and Services
Table 160. Performance Health OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Performance Health Recent Developments/Updates
Table 162. Performance Health Competitive Strengths & Weaknesses
Table 163. Actavis Basic Information, Manufacturing Base and Competitors
Table 164. Actavis Major Business
Table 165. Actavis OTC Transdermal Analgesic Patches Product and Services
Table 166. Actavis OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Actavis Recent Developments/Updates
Table 168. Actavis Competitive Strengths & Weaknesses
Table 169. Teikoku Seiyaku Basic Information, Manufacturing Base and Competitors
Table 170. Teikoku Seiyaku Major Business
Table 171. Teikoku Seiyaku OTC Transdermal Analgesic Patches Product and Services
Table 172. Teikoku Seiyaku OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Teikoku Seiyaku Recent Developments/Updates
Table 174. Novartis Basic Information, Manufacturing Base and Competitors
Table 175. Novartis Major Business
Table 176. Novartis OTC Transdermal Analgesic Patches Product and Services
Table 177. Novartis OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of OTC Transdermal Analgesic Patches Upstream (Raw Materials)
Table 179. OTC Transdermal Analgesic Patches Typical Customers
Table 180. OTC Transdermal Analgesic Patches Typical Distributors
Table 1. World OTC Transdermal Analgesic Patches Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World OTC Transdermal Analgesic Patches Production Value by Region (2018-2023) & (USD Million)
Table 3. World OTC Transdermal Analgesic Patches Production Value by Region (2024-2029) & (USD Million)
Table 4. World OTC Transdermal Analgesic Patches Production Value Market Share by Region (2018-2023)
Table 5. World OTC Transdermal Analgesic Patches Production Value Market Share by Region (2024-2029)
Table 6. World OTC Transdermal Analgesic Patches Production by Region (2018-2023) & (K Units)
Table 7. World OTC Transdermal Analgesic Patches Production by Region (2024-2029) & (K Units)
Table 8. World OTC Transdermal Analgesic Patches Production Market Share by Region (2018-2023)
Table 9. World OTC Transdermal Analgesic Patches Production Market Share by Region (2024-2029)
Table 10. World OTC Transdermal Analgesic Patches Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World OTC Transdermal Analgesic Patches Average Price by Region (2024-2029) & (US$/Unit)
Table 12. OTC Transdermal Analgesic Patches Major Market Trends
Table 13. World OTC Transdermal Analgesic Patches Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World OTC Transdermal Analgesic Patches Consumption by Region (2018-2023) & (K Units)
Table 15. World OTC Transdermal Analgesic Patches Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World OTC Transdermal Analgesic Patches Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key OTC Transdermal Analgesic Patches Producers in 2022
Table 18. World OTC Transdermal Analgesic Patches Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key OTC Transdermal Analgesic Patches Producers in 2022
Table 20. World OTC Transdermal Analgesic Patches Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global OTC Transdermal Analgesic Patches Company Evaluation Quadrant
Table 22. World OTC Transdermal Analgesic Patches Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and OTC Transdermal Analgesic Patches Production Site of Key Manufacturer
Table 24. OTC Transdermal Analgesic Patches Market: Company Product Type Footprint
Table 25. OTC Transdermal Analgesic Patches Market: Company Product Application Footprint
Table 26. OTC Transdermal Analgesic Patches Competitive Factors
Table 27. OTC Transdermal Analgesic Patches New Entrant and Capacity Expansion Plans
Table 28. OTC Transdermal Analgesic Patches Mergers & Acquisitions Activity
Table 29. United States VS China OTC Transdermal Analgesic Patches Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China OTC Transdermal Analgesic Patches Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China OTC Transdermal Analgesic Patches Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers OTC Transdermal Analgesic Patches Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers OTC Transdermal Analgesic Patches Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share (2018-2023)
Table 37. China Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers OTC Transdermal Analgesic Patches Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers OTC Transdermal Analgesic Patches Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share (2018-2023)
Table 42. Rest of World Based OTC Transdermal Analgesic Patches Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share (2018-2023)
Table 47. World OTC Transdermal Analgesic Patches Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World OTC Transdermal Analgesic Patches Production by Type (2018-2023) & (K Units)
Table 49. World OTC Transdermal Analgesic Patches Production by Type (2024-2029) & (K Units)
Table 50. World OTC Transdermal Analgesic Patches Production Value by Type (2018-2023) & (USD Million)
Table 51. World OTC Transdermal Analgesic Patches Production Value by Type (2024-2029) & (USD Million)
Table 52. World OTC Transdermal Analgesic Patches Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World OTC Transdermal Analgesic Patches Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World OTC Transdermal Analgesic Patches Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World OTC Transdermal Analgesic Patches Production by Application (2018-2023) & (K Units)
Table 56. World OTC Transdermal Analgesic Patches Production by Application (2024-2029) & (K Units)
Table 57. World OTC Transdermal Analgesic Patches Production Value by Application (2018-2023) & (USD Million)
Table 58. World OTC Transdermal Analgesic Patches Production Value by Application (2024-2029) & (USD Million)
Table 59. World OTC Transdermal Analgesic Patches Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World OTC Transdermal Analgesic Patches Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Hisamitsu Basic Information, Manufacturing Base and Competitors
Table 62. Hisamitsu Major Business
Table 63. Hisamitsu OTC Transdermal Analgesic Patches Product and Services
Table 64. Hisamitsu OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Hisamitsu Recent Developments/Updates
Table 66. Hisamitsu Competitive Strengths & Weaknesses
Table 67. Mylan Basic Information, Manufacturing Base and Competitors
Table 68. Mylan Major Business
Table 69. Mylan OTC Transdermal Analgesic Patches Product and Services
Table 70. Mylan OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Mylan Recent Developments/Updates
Table 72. Mylan Competitive Strengths & Weaknesses
Table 73. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 74. Johnson & Johnson Major Business
Table 75. Johnson & Johnson OTC Transdermal Analgesic Patches Product and Services
Table 76. Johnson & Johnson OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Johnson & Johnson Recent Developments/Updates
Table 78. Johnson & Johnson Competitive Strengths & Weaknesses
Table 79. Teva Basic Information, Manufacturing Base and Competitors
Table 80. Teva Major Business
Table 81. Teva OTC Transdermal Analgesic Patches Product and Services
Table 82. Teva OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Teva Recent Developments/Updates
Table 84. Teva Competitive Strengths & Weaknesses
Table 85. Lingrui Basic Information, Manufacturing Base and Competitors
Table 86. Lingrui Major Business
Table 87. Lingrui OTC Transdermal Analgesic Patches Product and Services
Table 88. Lingrui OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Lingrui Recent Developments/Updates
Table 90. Lingrui Competitive Strengths & Weaknesses
Table 91. Sanofi Basic Information, Manufacturing Base and Competitors
Table 92. Sanofi Major Business
Table 93. Sanofi OTC Transdermal Analgesic Patches Product and Services
Table 94. Sanofi OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Sanofi Recent Developments/Updates
Table 96. Sanofi Competitive Strengths & Weaknesses
Table 97. Qizheng Basic Information, Manufacturing Base and Competitors
Table 98. Qizheng Major Business
Table 99. Qizheng OTC Transdermal Analgesic Patches Product and Services
Table 100. Qizheng OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Qizheng Recent Developments/Updates
Table 102. Qizheng Competitive Strengths & Weaknesses
Table 103. Endo Basic Information, Manufacturing Base and Competitors
Table 104. Endo Major Business
Table 105. Endo OTC Transdermal Analgesic Patches Product and Services
Table 106. Endo OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Endo Recent Developments/Updates
Table 108. Endo Competitive Strengths & Weaknesses
Table 109. Huarun 999 Basic Information, Manufacturing Base and Competitors
Table 110. Huarun 999 Major Business
Table 111. Huarun 999 OTC Transdermal Analgesic Patches Product and Services
Table 112. Huarun 999 OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Huarun 999 Recent Developments/Updates
Table 114. Huarun 999 Competitive Strengths & Weaknesses
Table 115. GSK Basic Information, Manufacturing Base and Competitors
Table 116. GSK Major Business
Table 117. GSK OTC Transdermal Analgesic Patches Product and Services
Table 118. GSK OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. GSK Recent Developments/Updates
Table 120. GSK Competitive Strengths & Weaknesses
Table 121. Haw Par Basic Information, Manufacturing Base and Competitors
Table 122. Haw Par Major Business
Table 123. Haw Par OTC Transdermal Analgesic Patches Product and Services
Table 124. Haw Par OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Haw Par Recent Developments/Updates
Table 126. Haw Par Competitive Strengths & Weaknesses
Table 127. Nichiban Basic Information, Manufacturing Base and Competitors
Table 128. Nichiban Major Business
Table 129. Nichiban OTC Transdermal Analgesic Patches Product and Services
Table 130. Nichiban OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Nichiban Recent Developments/Updates
Table 132. Nichiban Competitive Strengths & Weaknesses
Table 133. Laboratoires Genevrier Basic Information, Manufacturing Base and Competitors
Table 134. Laboratoires Genevrier Major Business
Table 135. Laboratoires Genevrier OTC Transdermal Analgesic Patches Product and Services
Table 136. Laboratoires Genevrier OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Laboratoires Genevrier Recent Developments/Updates
Table 138. Laboratoires Genevrier Competitive Strengths & Weaknesses
Table 139. BLUE-EMU Basic Information, Manufacturing Base and Competitors
Table 140. BLUE-EMU Major Business
Table 141. BLUE-EMU OTC Transdermal Analgesic Patches Product and Services
Table 142. BLUE-EMU OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. BLUE-EMU Recent Developments/Updates
Table 144. BLUE-EMU Competitive Strengths & Weaknesses
Table 145. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 146. IBSA Group Major Business
Table 147. IBSA Group OTC Transdermal Analgesic Patches Product and Services
Table 148. IBSA Group OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. IBSA Group Recent Developments/Updates
Table 150. IBSA Group Competitive Strengths & Weaknesses
Table 151. Pfizer Basic Information, Manufacturing Base and Competitors
Table 152. Pfizer Major Business
Table 153. Pfizer OTC Transdermal Analgesic Patches Product and Services
Table 154. Pfizer OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Pfizer Recent Developments/Updates
Table 156. Pfizer Competitive Strengths & Weaknesses
Table 157. Performance Health Basic Information, Manufacturing Base and Competitors
Table 158. Performance Health Major Business
Table 159. Performance Health OTC Transdermal Analgesic Patches Product and Services
Table 160. Performance Health OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Performance Health Recent Developments/Updates
Table 162. Performance Health Competitive Strengths & Weaknesses
Table 163. Actavis Basic Information, Manufacturing Base and Competitors
Table 164. Actavis Major Business
Table 165. Actavis OTC Transdermal Analgesic Patches Product and Services
Table 166. Actavis OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Actavis Recent Developments/Updates
Table 168. Actavis Competitive Strengths & Weaknesses
Table 169. Teikoku Seiyaku Basic Information, Manufacturing Base and Competitors
Table 170. Teikoku Seiyaku Major Business
Table 171. Teikoku Seiyaku OTC Transdermal Analgesic Patches Product and Services
Table 172. Teikoku Seiyaku OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Teikoku Seiyaku Recent Developments/Updates
Table 174. Novartis Basic Information, Manufacturing Base and Competitors
Table 175. Novartis Major Business
Table 176. Novartis OTC Transdermal Analgesic Patches Product and Services
Table 177. Novartis OTC Transdermal Analgesic Patches Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of OTC Transdermal Analgesic Patches Upstream (Raw Materials)
Table 179. OTC Transdermal Analgesic Patches Typical Customers
Table 180. OTC Transdermal Analgesic Patches Typical Distributors
LIST OF FIGURES
Figure 1. OTC Transdermal Analgesic Patches Picture
Figure 2. World OTC Transdermal Analgesic Patches Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World OTC Transdermal Analgesic Patches Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World OTC Transdermal Analgesic Patches Production (2018-2029) & (K Units)
Figure 5. World OTC Transdermal Analgesic Patches Average Price (2018-2029) & (US$/Unit)
Figure 6. World OTC Transdermal Analgesic Patches Production Value Market Share by Region (2018-2029)
Figure 7. World OTC Transdermal Analgesic Patches Production Market Share by Region (2018-2029)
Figure 8. North America OTC Transdermal Analgesic Patches Production (2018-2029) & (K Units)
Figure 9. Europe OTC Transdermal Analgesic Patches Production (2018-2029) & (K Units)
Figure 10. China OTC Transdermal Analgesic Patches Production (2018-2029) & (K Units)
Figure 11. Japan OTC Transdermal Analgesic Patches Production (2018-2029) & (K Units)
Figure 12. OTC Transdermal Analgesic Patches Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 15. World OTC Transdermal Analgesic Patches Consumption Market Share by Region (2018-2029)
Figure 16. United States OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 17. China OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 18. Europe OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 19. Japan OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 20. South Korea OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 21. ASEAN OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 22. India OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of OTC Transdermal Analgesic Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for OTC Transdermal Analgesic Patches Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for OTC Transdermal Analgesic Patches Markets in 2022
Figure 26. United States VS China: OTC Transdermal Analgesic Patches Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: OTC Transdermal Analgesic Patches Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: OTC Transdermal Analgesic Patches Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share 2022
Figure 30. China Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share 2022
Figure 31. Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share 2022
Figure 32. World OTC Transdermal Analgesic Patches Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World OTC Transdermal Analgesic Patches Production Value Market Share by Type in 2022
Figure 34. Lidocaine Patches
Figure 35. Diclofenac Patches
Figure 36. Indomethacin Patches
Figure 37. Counter-Irritant Patches
Figure 38. Others
Figure 39. World OTC Transdermal Analgesic Patches Production Market Share by Type (2018-2029)
Figure 40. World OTC Transdermal Analgesic Patches Production Value Market Share by Type (2018-2029)
Figure 41. World OTC Transdermal Analgesic Patches Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World OTC Transdermal Analgesic Patches Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World OTC Transdermal Analgesic Patches Production Value Market Share by Application in 2022
Figure 44. Pharmacy
Figure 45. Clinic
Figure 46. Others
Figure 47. World OTC Transdermal Analgesic Patches Production Market Share by Application (2018-2029)
Figure 48. World OTC Transdermal Analgesic Patches Production Value Market Share by Application (2018-2029)
Figure 49. World OTC Transdermal Analgesic Patches Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. OTC Transdermal Analgesic Patches Industry Chain
Figure 51. OTC Transdermal Analgesic Patches Procurement Model
Figure 52. OTC Transdermal Analgesic Patches Sales Model
Figure 53. OTC Transdermal Analgesic Patches Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Figure 1. OTC Transdermal Analgesic Patches Picture
Figure 2. World OTC Transdermal Analgesic Patches Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World OTC Transdermal Analgesic Patches Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World OTC Transdermal Analgesic Patches Production (2018-2029) & (K Units)
Figure 5. World OTC Transdermal Analgesic Patches Average Price (2018-2029) & (US$/Unit)
Figure 6. World OTC Transdermal Analgesic Patches Production Value Market Share by Region (2018-2029)
Figure 7. World OTC Transdermal Analgesic Patches Production Market Share by Region (2018-2029)
Figure 8. North America OTC Transdermal Analgesic Patches Production (2018-2029) & (K Units)
Figure 9. Europe OTC Transdermal Analgesic Patches Production (2018-2029) & (K Units)
Figure 10. China OTC Transdermal Analgesic Patches Production (2018-2029) & (K Units)
Figure 11. Japan OTC Transdermal Analgesic Patches Production (2018-2029) & (K Units)
Figure 12. OTC Transdermal Analgesic Patches Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 15. World OTC Transdermal Analgesic Patches Consumption Market Share by Region (2018-2029)
Figure 16. United States OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 17. China OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 18. Europe OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 19. Japan OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 20. South Korea OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 21. ASEAN OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 22. India OTC Transdermal Analgesic Patches Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of OTC Transdermal Analgesic Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for OTC Transdermal Analgesic Patches Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for OTC Transdermal Analgesic Patches Markets in 2022
Figure 26. United States VS China: OTC Transdermal Analgesic Patches Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: OTC Transdermal Analgesic Patches Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: OTC Transdermal Analgesic Patches Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share 2022
Figure 30. China Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share 2022
Figure 31. Rest of World Based Manufacturers OTC Transdermal Analgesic Patches Production Market Share 2022
Figure 32. World OTC Transdermal Analgesic Patches Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World OTC Transdermal Analgesic Patches Production Value Market Share by Type in 2022
Figure 34. Lidocaine Patches
Figure 35. Diclofenac Patches
Figure 36. Indomethacin Patches
Figure 37. Counter-Irritant Patches
Figure 38. Others
Figure 39. World OTC Transdermal Analgesic Patches Production Market Share by Type (2018-2029)
Figure 40. World OTC Transdermal Analgesic Patches Production Value Market Share by Type (2018-2029)
Figure 41. World OTC Transdermal Analgesic Patches Average Price by Type (2018-2029) & (US$/Unit)
Figure 42. World OTC Transdermal Analgesic Patches Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 43. World OTC Transdermal Analgesic Patches Production Value Market Share by Application in 2022
Figure 44. Pharmacy
Figure 45. Clinic
Figure 46. Others
Figure 47. World OTC Transdermal Analgesic Patches Production Market Share by Application (2018-2029)
Figure 48. World OTC Transdermal Analgesic Patches Production Value Market Share by Application (2018-2029)
Figure 49. World OTC Transdermal Analgesic Patches Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. OTC Transdermal Analgesic Patches Industry Chain
Figure 51. OTC Transdermal Analgesic Patches Procurement Model
Figure 52. OTC Transdermal Analgesic Patches Sales Model
Figure 53. OTC Transdermal Analgesic Patches Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
